logo
October 13 - 14, 2019 | Dallas

John Vandermosten

speaker photo BIOTECH

Senior Biotechnology Research Analyst

Zacks Investment Research

John Vandermosten is currently a senior biotechnology research analyst for Zacks Investment Research where he covers a portfolio of small-cap biotechnology names. His background includes 17 years of experience in a variety of investment management and research roles across all market cap ranges and throughout the capital structure. Formerly, Mr. Vandermosten was a research analyst for Singular Research covering the healthcare space and a consultant with Coker Group, a national healthcare services firm providing financial advisory, investment banking, healthcare IT, and other services to hospitals and other health care organizations.

Speaker Schedule

Emerging Trends in Global Drug Development
October 13, 2019, 5:00 pm - 5:45 pm

Focus: ALTERNATIVE INVESTMENTS